KeifeRx to Headline Partner Spotlight on Brain Health Innovation at The Third Line Summit, November 19 in Washington, DC

–(BUSINESS WIRE)–KeifeRx: WHAT: A Partner Spotlight conversation, “Advancing Neurodegenerative Disease Treatment: From Discovery to Patient Care,” featuring KeifeRx, a Georgetown University spinout developing disease-modifying medicines for dementia and other neurodegenerative diseases. KeifeRx is a Leadership Partner of the Summit. WHO: Chris Hoyt, CEO & Board Member, KeifeRx, in conversation with Sia Anagnostou, Summit Co-Chair and Head of Programming & Strategic Partnerships, The T

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.